Literature DB >> 16678123

ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion.

Alan C Moss1, Garrett Lawlor, David Murray, Dónal Tighe, Stephen F Madden, Anne-Marie Mulligan, Conor O Keane, Hugh R Brady, Peter P Doran, Padraic MacMathuna.   

Abstract

We have identified novel colorectal cancer-associated genes using NCBI's UNIGENE cDNA libraries. Colon cancer libraries were examined using Digital Differential Display and disease-associated genes were selected. Among these were ETV4 and MYEOV, novel colorectal cancer-associated genes. Samples of matched normal and neoplastic colon were obtained from human subjects and gene expression was quantified using real-time PCR. ETV4 gene expression was significantly increased in colonic neoplasia in comparison to matched normal colonic tissue (p<0.05). Myeov expression was also increased in colon neoplasia in comparison to matched normal tissue. The effect of siRNA-mediated knockdown of ETV4 and Myeov on cell proliferation and invasion was assessed. ETV4 knockdown resulted in a 90% decrease in cell proliferation (p<0.05) and a 67% decrease in cell invasion. Myeov knockdown resulted in a 48% decrease in cell proliferation (p<0.05) and a 36% decrease in cell invasion. These data suggest that ETV4 and Myeov may provide novel targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678123     DOI: 10.1016/j.bbrc.2006.04.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 2.  ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta       Date:  2012-03-08

3.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

4.  A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.

Authors:  Sha Tao; Zhong Wang; Junjie Feng; Fang-Chi Hsu; Guangfu Jin; Seong-Tae Kim; Zheng Zhang; Henrik Gronberg; Lilly S Zheng; William B Isaacs; Jianfeng Xu; Jielin Sun
Journal:  Carcinogenesis       Date:  2012-01-04       Impact factor: 4.944

5.  Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma.

Authors:  Rui Tang; Jianmei Ji; Jun Ding; Jinxin Huang; Biao Gong; Xiwen Zhang; Fu Li
Journal:  Cell Cycle       Date:  2020-05-18       Impact factor: 4.534

6.  Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer.

Authors:  Candida Deves; Daiana Renck; Bernardo Garicochea; Vinicius Duval da Silva; Tiago Giulianni Lopes; Henrique Fillman; Lucio Fillman; Silvana Lunardini; Luis Augusto Basso; Diogenes Santiago Santos; Eraldo L Batista
Journal:  Virchows Arch       Date:  2011-02-12       Impact factor: 4.064

7.  MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2.

Authors:  Garrett Lawlor; Peter P Doran; Padraic MacMathuna; David W Murray
Journal:  J Exp Clin Cancer Res       Date:  2010-06-22

8.  ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.

Authors:  Nikhil Tyagi; Sachin K Deshmukh; Sanjeev K Srivastava; Shafquat Azim; Aamir Ahmad; Ahmed Al-Ghadhban; Ajay P Singh; James E Carter; Bin Wang; Seema Singh
Journal:  Mol Cancer Res       Date:  2017-11-08       Impact factor: 5.852

9.  MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity.

Authors:  Erbo Liang; Yishi Lu; Yanqiang Shi; Qian Zhou; Fachao Zhi
Journal:  Oncogene       Date:  2020-09-02       Impact factor: 9.867

10.  Divergent transcription: a driving force for new gene origination?

Authors:  Xuebing Wu; Phillip A Sharp
Journal:  Cell       Date:  2013-11-21       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.